Kansas Medicaid Supplemental Drug Rebate AgreementSupplemental Drug Rebate Agreement • December 16th, 2021 • Kansas
This Agreement is entered into by and between the Kansas Department of Health and Environment, Division of Health Care Finance, hereinafter referred to as KDHE-DHCF, located at 900 SW Jackson Street, Room 900N, Topeka, Kansas 66612-1220 and , hereinafter referred to as CONTRACTOR located at .
NATIONAL MEDICAID POOLING INITIATIVE (“NMPI”) SUPPLEMENTAL DRUG REBATE AGREEMENTSupplemental Drug Rebate Agreement • August 30th, 2017
VERMONT SUPPLEMENTAL DRUG-REBATE AGREEMENTSupplemental Drug-Rebate Agreement • May 5th, 2020
CONTRACT #____________________Supplemental Drug-Rebate Agreement • November 5th, 2021 • Missouri
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM SUPPLEMENTAL DRUG-REBATE AGREEMENT AHCCCS AGREEMENT #Supplemental Drug-Rebate Agreement • May 5th, 2020 • Arizona
This Agreement is entered into by the following parties on the date last signed below:Supplemental Drug-Rebate Agreement • March 22nd, 2024
Pharmaceutical Manufacturer ("Manufacturer") Department of Vermont Health Access ("The State") Labeler Codes: Department of Vermont Health Access Manufacturer Primary Billing Address: State Primary Billing Address: Change Healthcare, Vermont RebateP.O. Box 1038Augusta, ME 04332-1038 Manufacturer Primary Contact Person: State Primary Contact Person: Shari Martin Manufacturer Primary Contact Telephone: State Primary Contact Telephone: 207-622-7153 x71375 Manufacturer Primary Contact e-mail: State Primary Contact e-mail: PBA_srcontracts@changehealthcare.com Address for Notices required by Agreement("Manufacturer Notice Address"): Address for Notices required by Agreement: ("StateNotice Address"): State of VermontDepartment of Vermont Health Access Pharmacy Unit - Stacey Baker280 State Drive, NOB1 SouthSouth Waterbury, VT 05671 Termination Date: ("Termination Date") Effective Date ("Effective Date") 12/31/2025 01/01/2025
BUREAU FOR MEDICAL SERVICES SUPPLEMENTAL DRUG REBATE AGREEMENTSupplemental Drug Rebate Agreement • May 5th, 2020 • West Virginia
Supplemental Drug Rebate Agreements:Supplemental Drug Rebate Agreement • August 26th, 2024
The Division of Medicaid, or the Division of Medicaid in consultation with the Sovereign States Drug Consortium, may negotiate supplemental drug rebate agreements (SDRAs) that would reclassify any drug not designated as preferred in the baseline listing for as long as the agreement is in effect. A SDRA between the Division of Medicaid and a drug manufacturer for drugs provided to the Medicaid program, submitted to the Centers for Medicare & Medicaid Services (CMS) on December 27, 2005 and entitled, “State of Mississippi Supplemental Rebate Agreement”, was authorized by CMS. CMS authorized the State of Mississippi to enter into the “Sovereign States Drug Consortium (SSDC)” multi-state purchasing pool. The SDRA submitted to CMS on September 7, 2012, entitled, “State of Mississippi Supplemental Rebate Agreement”, was authorized by CMS. CMS authorized the revised multi-state SSDC agreement submitted on March 17, 2014, for the Division of Medicaid population to cover supplemental drug rebat
HEALTH AND HUMAN SERVICES COMMISSIONSupplemental Drug Rebate Agreement • February 2nd, 2018
The Texas Health and Human Services Commission (HHSC) announces its intent to submit transmittal number 18-0001 to the Texas State Plan for Medical Assistance, under Title XIX of the Social Security Act.
Supplemental Drug Rebate Agreements:Supplemental Drug Rebate Agreement • November 3rd, 2017
The Division of Medicaid, or the Division of Medicaid in consultation with the Sovereign States Drug Consortium, may negotiate supplemental drug rebate agreements (SDRAs) that would reclassify any drug not designated as preferred in the baseline listing for as long as the agreement is in effect. A SDRA between the Division of Medicaid and a drug manufacturer for drugs provided to the Medicaid program, submitted to the Centers for Medicare & Medicaid Services (CMS) on December 27, 2005 and entitled, “State of Mississippi Supplemental Rebate Agreement”, was authorized by CMS. CMS authorized the State of Mississippi to enter into the “Sovereign States Drug Consortium (SSDC)” multi-state purchasing pool. The SDRA submitted to CMS on September 7, 2012, entitled, “State of Mississippi Supplemental Rebate Agreement”, was authorized by CMS. CMS authorized the revised multi-state SSDC agreement submitted on March 17, 2014, for the Division of Medicaid population to cover supplemental drug rebat
SUPPLEMENTAL DRUG-REBATE AGREEMENT CONTRACT # NMPI-Supplemental Drug-Rebate Agreement • October 11th, 2012
Dear Participating Pharmaceutical Manufacturer:Supplemental Drug Rebate Agreement • October 21st, 2024
Thank you for your continued participation in the National Medicaid Pooling Initiative (“NMPI”) administered by Prime Therapeutics, on behalf of our state Medicaid clients.
VERMONT SUPPLEMENTAL DRUG REBATE AGREEMENTSupplemental Drug Rebate Agreement • May 5th, 2020
